Pathophysiologically based treatment interventions in schizophrenia (original) (raw)

• Hyman, S.E. & Fenton, W.S. Medicine. What are the right targets for psychopharmacology? Science 299, 350–351 (2003).
  Article CAS PubMed Google Scholar
• Lieberman, J.A. et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353, 1209–1223 (2005).
  Article CAS PubMed Google Scholar
• Insel, T.R. & Scolnick, E.M. Cure therapeutics and strategic prevention: raising the bar for mental health research. Mol. Psychiatry 11, 11–17 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Harrison, P.J. & Weinberger, D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 40–68 (2005).
  Article CAS PubMed Google Scholar
• Lewis, D.A. & Levitt, P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25, 409–432 (2002).
  Article CAS PubMed Google Scholar
• Lewis, D.A., Hashimoto, T. & Volk, D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6, 312–324 (2005).
  Article CAS PubMed Google Scholar
• Mirnics, K., Levitt, P. & Lewis, D.A. Critical appraisal of DNA microarrays in psychiatric genomics. Biol. Psychiatry 60, 163–176 (2006).
  Article CAS PubMed Google Scholar
• Lewis, D.A. The human brain revisited: Opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology 26, 143–154 (2002).
  Article PubMed Google Scholar
• Elvevag, B. & Goldberg, T.E. Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 14, 1–21 (2000).
  Article CAS PubMed Google Scholar
• Gold, J.M. Cognitive deficits as treatment targets in schizophrenia. Schizophr. Res. 72, 21–28 (2004).
  Article PubMed Google Scholar
• Keefe, R.S., Eesley, C.E. & Poe, M.P. Defining a cognitive function decrement in schizophrenia. Biol. Psychiatry 57, 688–691 (2005).
  Article PubMed Google Scholar
• Green, M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153, 321–330 (1996).
  Article CAS PubMed Google Scholar
• Baddeley, A. Working memory. Science 255, 556–559 (1992).
  Article CAS PubMed Google Scholar
• Barch, D.M. What can research on schizophrenia tell us about the cognitive neuroscience of working memory? Neuroscience 139, 73–84 (2006).
  Article CAS PubMed Google Scholar
• Tan, H.Y., Choo, W.C., Fones, C.S. & Chee, M.W. fMRI study of maintenance and manipulation processes within working memory in first-episode schizophrenia. Am. J. Psychiatry 162, 1849–1858 (2005).
  Article PubMed Google Scholar
• Cannon, T.D. et al. Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia. Arch. Gen. Psychiatry 62, 1071–1080 (2005).
  Article PubMed Google Scholar
• Callicott, J.H. et al. Complexity of prefrontal cortical dysfunction in schizophrenia: More than up or down. Am. J. Psychiatry 160, 2209–2215 (2003).
  Article PubMed Google Scholar
• MacDonald, A.W., III et al. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am. J. Psychiatry 162, 475–484 (2005).
  Article PubMed Google Scholar
• Barch, D.M., Sheline, Y.I., Csernansky, J.G. & Snyder, A.Z. Working memory and prefrontal cortex dysfunction: Specificity to schizophrenia compared with major depression. Biol. Psychiatry 53, 376–384 (2003).
  Article PubMed Google Scholar
• Olney, J.W. & Farber, N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52, 998–1007 (1995).
  Article CAS PubMed Google Scholar
• Moghaddam, B. Bringing order to the glutamate chaos in schizophrenia. Neuron 40, 881–884 (2003).
  Article CAS PubMed Google Scholar
• Coyle, J.T. The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem. Pharmacol. 68, 1507–1514 (2004).
  Article CAS PubMed Google Scholar
• Krystal, J.H. et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51, 199–214 (1994).
  Article CAS PubMed Google Scholar
• Adler, C.M. et al. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am. J. Psychiatry 156, 1646–1649 (1999).
  Article CAS PubMed Google Scholar
• Verma, A. & Moghaddam, B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J. Neurosci. 16, 373–379 (1996).
  Article CAS PubMed Google Scholar
• Dudkin, K.N., Kruchinin, V.K. & Chueva, I.V. Neurophysiological correlates of delayed visual differentiation tasks in monkeys: the effects of the site of intracortical blockade of NMDA receptors. Neurosci. Behav. Physiol. 31, 207–218 (2001).
  Article CAS PubMed Google Scholar
• Wang, X.J. Toward a prefrontal microcircuit model for cognitive deficits in schizophrenia. Pharmacopsychiatry 39 Suppl 1, S80–S87 (2006).
  Article PubMed Google Scholar
• Durstewitz, D. & Seamans, J.K. Beyond bistability: biophysics and temporal dynamics of working memory. Neuroscience 139, 119–133 (2006).
  Article CAS PubMed Google Scholar
• Goldman-Rakic, P.S. Cellular basis of working memory. Neuron 14, 477–485 (1995).
  Article CAS PubMed Google Scholar
• Scherzer, C.R. et al. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex. J. Comp. Neurol. 390, 75–90 (1998).
  Article CAS PubMed Google Scholar
• Konradi, C. & Heckers, S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol. Ther. 97, 153–179 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kristiansen, L.V., Beneyto, M., Haroutunian, V. & Meador-Woodruff, J.H. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol. Psychiatry 11, 737–747 (2006).
  Article CAS PubMed Google Scholar
• Akbarian, S. et al. Selective alterations in gene expression of NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16, 19–30 (1996).
  Article CAS PubMed Google Scholar
• Dracheva, S. et al. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am. J. Psychiatry 158, 1400–1410 (2001).
  Article CAS PubMed Google Scholar
• Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A. & Levitt, P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53–67 (2000).
  Article CAS PubMed Google Scholar
• Tsai, G. et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch. Gen. Psychiatry 52, 829–836 (1995).
  Article CAS PubMed Google Scholar
• Hakak, Y. et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 98, 4746–4751 (2001).
  Article CAS PubMed Google Scholar
• Stefansson, H. et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877–892 (2002).
  Article PubMed PubMed Central Google Scholar
• Munafo, M.R., Thiselton, D.L., Clark, T.G. & Flint, J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol. Psychiatry 11, 539–546 (2006).
  Article CAS PubMed Google Scholar
• Tosato, S., Dazzan, P. & Collier, D. Association between the neuregulin 1 gene and schizophrenia: a systematic review. Schizophr. Bull. 31, 613–617 (2005).
  Article PubMed Google Scholar
• Hahn, C.G. et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia. Nat Med. 12, 824–828 (2006).
  Article CAS PubMed Google Scholar
• Law, A.J. et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc. Natl. Acad. Sci. USA 103, 6747–6752 (2006).
  Article CAS PubMed Google Scholar
• Carlsson, A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 39 Suppl 1, S10–S14 (2006).
  Article CAS PubMed Google Scholar
• Weinberger, D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44, 660–669 (1987).
  Article CAS PubMed Google Scholar
• Davis, K.L., Kahn, R.S., Ko, G. & Davidson, M. Dopamine in schizophrenia: A review and reconceptualization. Am. J. Psychiatry 148, 1474–1486 (1991).
  Article CAS PubMed Google Scholar
• Brozoski, T.J., Brown, R.M., Rosvold, H.E. & Goldman, P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkeys. Science 205, 929–932 (1979).
  Article CAS PubMed Google Scholar
• Sawaguchi, T. & Goldman-Rakic, P.S. D1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science 251, 947–950 (1991).
  Article CAS PubMed Google Scholar
• Sawaguchi, T. & Goldman-Rakic, P.S. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J. Neurophysiol. 71, 515–528 (1994).
  Article CAS PubMed Google Scholar
• Goldman-Rakic, P.S., Lidow, M.S. & Gallagher, D.W. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci. 10, 2125–2138 (1990).
  Article CAS PubMed Google Scholar
• González-Burgos, G. et al. Dopamine modulation of neuronal function in the monkey prefrontal cortex. Physiol. Behav. 77, 537–543 (2002).
  Article PubMed Google Scholar
• Williams, G.V. & Goldman-Rakic, P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376, 572–575 (1995).
  Article CAS PubMed Google Scholar
• Sawaguchi, T. The effects of dopamine and its antagonists on directional delay-period activity of prefrontal neurons in monkeys during an oculomotor delayed-response task. Neurosci. Res. 41, 115–128 (2001).
  Article CAS PubMed Google Scholar
• Akil, M. et al. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry 156, 1580–1589 (1999).
  Article CAS PubMed Google Scholar
• Abi-Dargham, A. et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J. Neurosci. 22, 3708–3719 (2002).
  Article CAS PubMed Google Scholar
• Okubo, Y. et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385, 634–636 (1997).
  Article CAS PubMed Google Scholar
• Abi-Dargham, A. & Moore, H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9, 404–416 (2003).
  Article CAS PubMed Google Scholar
• Lewis, D.A. et al. Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar and ultrastructural localization. J. Comp. Neurol. 432, 119–138 (2001).
  Article CAS PubMed Google Scholar
• Tunbridge, E.M., Bannerman, D.M., Sharp, T. & Harrison, P.J. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J. Neurosci. 24, 5331–5335 (2004).
  Article CAS PubMed Google Scholar
• Chen, J. et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 75, 807–821 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Egan, M.F. et al. Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA 98, 6917–6922 (2001).
  Article CAS PubMed Google Scholar
• Meyer-Lindenberg, A. et al. Impact of complex genetic variation in COMT on human brain function. Mol. Psychiatry advance online publication 20 June 2006 (doi:10.1038/sj.mp.4001860).
• Sesack, S.R. & Carr, D.B. Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol. Behav. 77, 513–517 (2002).
  Article CAS PubMed Google Scholar
• Kellendonk, C. et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49, 603–615 (2006).
  Article CAS PubMed Google Scholar
• Laruelle, M. Dopamine transmission in the schizophrenic brain. in Schizophrenia (eds. Hirsch, S.R. & Weinberger, D.) 365–386 (Blackwell Publishing Co., Malden, Massachusetts, 2003).
  Chapter Google Scholar
• Rao, S.G., Williams, G.V. & Goldman-Rakic, P.S. Destruction and creation of spatial tuning by disinhibition: GABAA blockade of prefrontal cortical neurons engaged by working memory. J. Neurosci. 20, 485–494 (2000).
  Article CAS PubMed Google Scholar
• Sawaguchi, T., Matsumura, M. & Kubota, K. Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys. Exp. Brain Res. 75, 457–469 (1989).
  Article CAS PubMed Google Scholar
• Akbarian, S. et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258–266 (1995).
  Article CAS PubMed Google Scholar
• Volk, D.W., Austin, M.C., Pierri, J.N., Sampson, A.R. & Lewis, D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 57, 237–245 (2000).
  Article CAS PubMed Google Scholar
• Volk, D., Austin, M.C., Pierri, J.N., Sampson, A.R. & Lewis, D.A. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: Decreased expression in a subset of neurons. Am. J. Psychiatry 158, 256–265 (2001).
  Article CAS PubMed Google Scholar
• Hashimoto, T. et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 23, 6315–6326 (2003).
  Article CAS PubMed Google Scholar
• Woo, T-U., Whitehead, R.E., Melchitzky, D.S. & Lewis, D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. USA 95, 5341–5346 (1998).
  Article CAS PubMed Google Scholar
• Volk, D.W. et al. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb. Cortex 12, 1063–1070 (2002).
  Article PubMed Google Scholar
• Whittington, M.A. & Traub, R.D. Interneuron diversity series: inhibitory interneurons and network oscillations in vitro. Trends Neurosci. 26, 676–682 (2003).
  Article CAS PubMed Google Scholar
• Howard, M.W. et al. Gamma oscillations correlate with working memory load in humans. Cereb. Cortex 13, 1369–1374 (2003).
  Article PubMed Google Scholar
• Cho, R.Y., Konecky, R.O. & Carter, C.S. Impairments in gamma band synchronization and context processing in schizophrenia. Schizophr. Bull. 31, 450–451 (2005).
  Article Google Scholar
• Akbarian, S. & Huang, H.S. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res. Brain Res. Rev. published online 8 June 2006 (doi:10.1016/j.brainresrev.2006.04.001).
• Spencer, K.M. et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc. Natl. Acad. Sci. USA 101, 17288–17293 (2004).
  Article CAS PubMed Google Scholar
• Goldman-Rakic, P.S., Castner, S.A., Svensson, T.H., Siever, L.J. & Williams, G.V. Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl.) 174, 3–16 (2004).
  Article CAS Google Scholar
• Coyle, J.T. & Tsai, G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl.) 174, 32–38 (2004).
  Article CAS Google Scholar
• Lewis, D.A., Volk, D.W. & Hashimoto, T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: A novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl.) 174, 143–150 (2004).
  Article CAS Google Scholar
• Torrey, E.F. et al. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 57, 252–260 (2005).
  Article CAS PubMed Google Scholar
• Jones, E.G. Cortical development and thalamic pathology in schizophrenia. Schizophr. Bull. 23, 483–501 (1997).
  Article CAS PubMed Google Scholar
• Lewis, D.A. & Moghaddam, B. Cognitive dysfuntion in schizophrenia: convergence of GABA and glutamate alterations. Arch. Neurol. (in the press).
• Gulyás, A.I., Megías, M., Emri, Z. & Freund, T.F. Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J. Neurosci. 19, 10082–10097 (1999).
  Article PubMed Google Scholar
• Melchitzky, D.S. & Lewis, D.A. Pyramidal neuron local axon terminals in monkey prefrontal cortex: Differential targeting of subclasses of GABA neurons. Cereb. Cortex 13, 452–460 (2003).
  Article PubMed Google Scholar
• Huntley, G.W. et al. Distribution and synaptic localization of immunocytochemically identified NMDA receptor subunit proteins in sensory-motor and visual cortices of monkey and human. J. Neurosci. 14, 3603–3619 (1994).
  Article CAS PubMed Google Scholar
• Huntley, G.W., Vickers, J.C. & Morrison, J.H. Quantitative localization of NMDAR1 receptor subunit immunoreactivity in inferotemporal and prefrontal association cortices of monkey and human. Brain Res. 749, 245–262 (1997).
  Article CAS PubMed Google Scholar
• Keilhoff, G., Becker, A., Grecksch, G., Wolf, G. & Bernstein, H.G. Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 126, 591–598 (2004).
  Article CAS PubMed Google Scholar
• Cochran, S.M. et al. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology 28, 265–275 (2003).
  Article CAS PubMed Google Scholar
• Kinney, J.W. et al. A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J. Neurosci. 26, 1604–1615 (2006).
  Article CAS PubMed Google Scholar
• Cunningham, M.O. et al. Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. J. Neurosci. 26, 2767–2776 (2006).
  Article CAS PubMed Google Scholar
• Woo, T.-U., Walsh, J.P. & Benes, F.M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 61, 649–657 (2004).
  Article CAS PubMed Google Scholar
• Corfas, G., Roy, K. & Buxbaum, J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 7, 575–580 (2004).
  Article CAS PubMed Google Scholar
• Flames, N. et al. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 44, 251–261 (2004).
  Article CAS PubMed Google Scholar
• Yau, H.J., Wang, H.F., Lai, C. & Liu, F.C. Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb. Cortex 13, 252–264 (2003).
  Article PubMed Google Scholar
• Tsukada, H. et al. Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys. Neuropsychopharmacology 30, 1861–1869 (2005).
  Article CAS PubMed Google Scholar
• Narendran, R. et al. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am. J. Psychiatry 162, 2352–2359 (2005).
  Article PubMed Google Scholar
• Sesack, S.R., Hawrylak, V.A., Melchitzky, D.S. & Lewis, D.A. Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: Ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. Cereb. Cortex 8, 614–622 (1998).
  Article CAS PubMed Google Scholar
• Muly, E.C., Szigeti, K. & Goldman-Rakic, P.S. D1 receptor in interneurons of macaque prefrontal cortex: Distribution and subcellular location. J. Neurosci. 18, 10553–10565 (1998).
  Article CAS PubMed Google Scholar
• Zaitsev, A.V. et al. Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb. Cortex 15, 1178–1186 (2005).
  Article CAS PubMed Google Scholar
• Kroner, S., Krimer, L.S., Lewis, D.A. & Barrionuevo, G. Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Cereb. Cortex (doi:10.1093/cercor/bhl012).
• Gonzalez-Burgos, G., Kroener, S., Seamans, J.K., Lewis, D.A. & Barrionuevo, G. Dopaminergic modulation of short-term synaptic plasticity in fast-spiking interneurons of primate dorsolateral prefrontal cortex. J. Neurophysiol. 94, 4168–4177 (2005).
  Article CAS PubMed Google Scholar
• Mann, E.O., Radcliffe, C.A. & Paulsen, O. Hippocampal gamma-frequency oscillations: from interneurones to pyramidal cells, and back. J. Physiol. (Lond.) 562, 55–63 (2005).
  Article CAS Google Scholar
• Addington, A.M. et al. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD(67)), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol. Psychiatry 10, 581–588 (2005).
  Article CAS PubMed Google Scholar
• Weickert, C.S. et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry 61, 544–555 (2004).
  Article CAS PubMed Google Scholar
• Straub, R.E. et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71, 337–348 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Millar, J.K. et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310, 1187–1191 (2005).
  Article CAS PubMed Google Scholar